CryoPort (NASDAQ:CYRX) Hits New 12-Month High on Analyst Upgrade
CryoPort (NASDAQ:CYRX) Sets New 1-Year High on Analyst Upgrade...
MarketBeat
More News
CryoPort (NASDAQ:CYRX) Shares Gap Up on Analyst Upgrade
CryoPort (NASDAQ:CYRX) Shares Gap Up Following Analyst Upgrade...
MarketBeat
CryoPort (NASDAQ:CYRX) Price Target Raised to $17.00
BTIG Research increased their price target on shares of CryoPort from $15.00 to $17.00 and gave the stock a 'buy' rating in a research note on Tuesday...
CryoPort (NASDAQ:CYRX) reported first-quarter fiscal 2026 results that management said reflected continued momentum across its integrated services and products platform, highlighted by double-digit...
MarketBeat
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CryoPort (CYRX) delivered earnings and revenue surprises of -15.00% and +6.41%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
CryoPort (NASDAQ:CYRX) Posts Earnings Results, Misses Expectations By $0.03 EPS
CryoPort (NASDAQ:CYRX - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.03). CryoPort...
MarketBeat
Cryoport Posts Revenue Beat In Q1 As Clinical Trial Support Hits All-Time High 'A Strong Start To 2026'
Cryoport released financial results for Q1 of fiscal 2026 Monday after the closing bell.read more...
Benzinga
Cryoport Reports First Quarter 2026 Financial Results
Cryoport Reports First Quarter 2026 Financial Results Cryoport Reports First Quarter 2026 Financial Results PR Newswire NASHVILLE, Tenn., May 4, 2026 First quarter revenue grew 16% year-over-year to...
PR Newswire
CryoPort (NASDAQ:CYRX) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded shares of CryoPort from a "hold" rating to a "sell" rating in a research report on Sunday...